Clinical Trials Logo

Baroreflex Failure Syndrome clinical trials

View clinical trials related to Baroreflex Failure Syndrome.

Filter by:
  • None
  • Page 1

NCT ID: NCT03730519 Terminated - Clinical trials for Hypertension, Resistant to Conventional Therapy

UK Registry for Baroreflex Activation Therapy

UK-BAT
Start date: November 1, 2018
Phase: N/A
Study type: Interventional

This study is a post-marketing open label single arm, single centre clinical trial of electrical carotid sinus stimulation with the Barostim Neo device to target sub-optimally controlled arterial hypertension or highly variable blood pressure in patients for whom no alternative therapies are available.

NCT ID: NCT02553265 Completed - Clinical trials for Baroreflex Failure Syndrome

Carbidopa for the Treatment of Excessive Blood Pressure Variability

CarbiFD
Start date: September 2015
Phase: Phase 2
Study type: Interventional

The overall study objectives are to determine whether carbidopa (Lodosyn®) is safe and well tolerated and to assess whether it can inhibit catecholamine-induced paroxysmal hypertension and normalize or reduce the exaggerated blood pressure variability in patients with familial dysautonomia (FD, also called hereditary sensory and autonomic neuropathy type III or Riley-Day syndrome). Funding Source- FDA OOPD.